<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50830</article-id><article-id pub-id-type="doi">10.7554/eLife.50830</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-152136"><name><surname>Pereira</surname><given-names>Joana B</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4604-2711</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-153355"><name><surname>Ossenkoppele</surname><given-names>Rik</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-153356"><name><surname>Palmqvist</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-153357"><name><surname>Strandberg</surname><given-names>Tor Olof</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-153358"><name><surname>Smith</surname><given-names>Ruben</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-153359"><name><surname>Westman</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-153360"><name><surname>Hansson</surname><given-names>Oskar</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society</institution>, <institution>Karolinska Institute</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff2"><institution content-type="dept">Department of Neurology and Alzheimer Center</institution>, <institution>VU University Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff3"><institution content-type="dept">Clinical Memory Research Unit, Department of Clinical Sciences</institution>, <institution>Lund University</institution>, <addr-line><named-content content-type="city">Lund</named-content></addr-line>, <country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-130588"><name><surname>Irish</surname><given-names>Muireann</given-names></name><role>Reviewing editor</role><aff><institution>University of Sydney</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>joana.pereira@ki.se</email> (JP);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>oskar.hansson@med.lu.se</email> (OH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>12</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e50830</elocation-id><history><date date-type="received"><day>04</day><month>08</month><year>2019</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Pereira et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Pereira et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-50830-v1.pdf"/><abstract><p>The abnormal accumulation of amyloid-β and tau targets specific spatial networks in Alzheimer's disease. However, the relationship between these networks across different disease stages and their association with brain connectivity has not been explored. In this study, we applied a joint independent component analysis to <sup>18</sup>F- Flutemetamol (amyloid-β) and <sup>18</sup>F-Flortaucipir (tau) PET images to identify amyloid-β and tau networks across different stages of Alzheimer's disease. We then assessed whether these patterns were associated with resting-state functional networks and white matter tracts. Our analyses revealed nine patterns that were linked across tau and amyloid-β data. The amyloid-b and tau patterns showed a fair to moderate overlap with distinct functional networks but only tau was associated with white matter integrity loss and multiple cognitive functions. These findings show that amyloid-b and tau have different spatial affinities, which can be used to understand how they accumulate in the brain and potentially damage the brain's connections.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>European Research Council, Swedish Research Council, Swedish Brain Foundation, Startneuro, Swedish Alzheimer Foundation, Knut and Alice Wallenberg foundation, Strategic Research Area Multipark</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hansson</surname><given-names>Oskar</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Swedish Research Council, Alzheimerfonden, Swedish Brain Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Pereira</surname><given-names>Joana B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Oskar Hansson, has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Biogen, Roche, and Fujirebio.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study received ethical approval from the Regional Ethical Review Board of Lund University (Dnr 2008-695, 2008-290, 2010-156), the Swedish Medicines and Products Agency (Dnr 151:2012/4552, 5.1-2014-62949), and the Radiation Safety Committee of Skåne University Hospital in Sweden. All participants provided informed consent before being included in the study.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Source data files have been provided for Figures 4 and 5. The source data for the rest of the analyses performed in this study can be requested from Prof. Oskar Hansson (Oskar.Hansson@med.lu.se), after signing a material transfer agreement from Lund University that ensures that the data will only be used for the sole purpose of replicating procedures and results presented in the article and as long as data transfer is in agreement with EU legislation on the general data protection regulation and decisions by the Ethical Review Board of Sweden and Region Skåne.</p></sec><supplementary-material><ext-link xlink:href="elife-50830-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>